James T. Riordan

924 total citations
24 papers, 705 citations indexed

About

James T. Riordan is a scholar working on Infectious Diseases, Genetics and Endocrinology. According to data from OpenAlex, James T. Riordan has authored 24 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 11 papers in Genetics and 11 papers in Endocrinology. Recurrent topics in James T. Riordan's work include Escherichia coli research studies (11 papers), Bacterial Genetics and Biotechnology (9 papers) and Viral gastroenteritis research and epidemiology (7 papers). James T. Riordan is often cited by papers focused on Escherichia coli research studies (11 papers), Bacterial Genetics and Biotechnology (9 papers) and Viral gastroenteritis research and epidemiology (7 papers). James T. Riordan collaborates with scholars based in United States, Australia and United Kingdom. James T. Riordan's co-authors include Thomas S. Whittam, John E. Gustafson, Shannon D. Manning, Avishek Mitra, Lindsey Ouellette, Harvey Liebhaber, Galeb Abu-Ali, David W. Lacher, Teresa M. Bergholz and Dirk Horstmann and has published in prestigious journals such as PLoS ONE, Journal of Bacteriology and Journal of Clinical Microbiology.

In The Last Decade

James T. Riordan

24 papers receiving 664 citations

Peers

Countries citing papers authored by James T. Riordan

Since Specialization

Citations

This map shows the geographic impact of James T. Riordan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James T. Riordan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James T. Riordan more than expected).

Fields of papers citing papers by James T. Riordan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James T. Riordan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James T. Riordan. The network helps show where James T. Riordan may publish in the future.

Co-authorship network of co-authors of James T. Riordan

This figure shows the co-authorship network connecting the top 25 collaborators of James T. Riordan. A scholar is included among the top collaborators of James T. Riordan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James T. Riordan. James T. Riordan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Regulation of Escherichia coli Pathogenesis by Alternative Sigma Factor N 2017 ·EcoSal Plus ·James T. Riordan, Avishek Mitra	19
2	The role for TolA in enterohemorrhagic Escherichia coli pathogenesis and virulence gene transcription 2014 ·Microbial Pathogenesis ·(unknown), J A Ortíz, James T. Riordan	27
3	RcsB determines the locus of enterocyte effacement (LEE) expression and adherence phenotype of Escherichia coli O157 : H7 spinach outbreak strain TW14359 and coordinates bicarbonate-dependent LEE activation with repression of motility 2013 ·Microbiology ·(unknown), (unknown), Stanley M. Stevens, James T. Riordan	13
4	Sigma Factor N, Liaison to an ntrC and rpoS Dependent Regulatory Pathway Controlling Acid Resistance and the LEE in Enterohemorrhagic Escherichia coli 2012 ·PLoS ONE ·Avishek Mitra, (unknown), (unknown), (unknown), (unknown), James T. Riordan	13
5	Shiga toxin 2 overexpression in Escherichia coli O157:H7 strains associated with severe human disease 2011 ·Microbial Pathogenesis ·(unknown), Galeb Abu-Ali, Avishek Mitra, David W. Lacher, Shannon D. Manning, James T. Riordan	50
6	Alterations in the transcriptome and antibiotic susceptibility of Staphylococcus aureus grown in the presence of diclofenac 2011 ·Annals of Clinical Microbiology and Antimicrobials ·James T. Riordan, (unknown), (unknown), (unknown), Yang Song, (unknown), (unknown), (unknown), Vijayaraj Nagarajan, Mohamed O. Elasri, Brian J. Wilkinson, John E. Gustafson	39
7	NsaRS is a cell-envelope-stress-sensing two-component system of Staphylococcus aureus 2011 ·Microbiology ·Stacey L. Kolar, Vijayaraj Nagarajan, Anna Oszmiana, Frances E. Rivera, Halie K. Miller, Jessica Davenport, James T. Riordan, Jan Potempa, David S. Barber, Joanna Kozieł, Mohamed O. Elasri, Lindsey N. Shaw	75
8	Increased Adherence and Expression of Virulence Genes in a Lineage of Escherichia coli O157:H7 Commonly Associated with Human Infections 2010 ·PLoS ONE ·Galeb Abu-Ali, Lindsey Ouellette, (unknown), David W. Lacher, James T. Riordan, Thomas S. Whittam, Shannon D. Manning	59
9	sarA inactivation reduces vancomycin-intermediate and ciprofloxacin resistance expression by Staphylococcus aureus 2009 ·International Journal of Antimicrobial Agents ·(unknown), (unknown), James T. Riordan, (unknown), (unknown), (unknown), (unknown), (unknown), Brian J. Wilkinson, John E. Gustafson	19
10	Inactivation of alternative sigma factor 54 (RpoN) leads to increased acid resistance, and alters locus of enterocyte effacement (LEE) expression in Escherichia coli O157 : H7 2009 ·Microbiology ·James T. Riordan, (unknown), (unknown), John E. Gustafson, Thomas S. Whittam	33
11	Genetic changes that correlate with the pine-oil disinfectant-reduced susceptibility mechanism ofStaphylococcus aureus 2008 ·Journal of Applied Microbiology ·(unknown), James T. Riordan, (unknown), Arunachalam Muthaiyan, (unknown), Brian J. Wilkinson, John E. Gustafson	3
12	Genetic Differentiation of Escherichia coli O157:H7 Clades Associated with Human Disease by Real-Time PCR 2008 ·Journal of Clinical Microbiology ·James T. Riordan, (unknown), Shannon D. Manning, Thomas S. Whittam	43
13	Global transcriptional response of Escherichia coli O157:H7 to growth transitions in glucose minimal medium 2007 ·BMC Microbiology ·Teresa M. Bergholz, Lukas M. Wick, Weihong Qi, James T. Riordan, Lindsey Ouellette, Thomas S. Whittam	71
14	Hetero-Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Isolate from a Medical Center in Las Cruces, New Mexico 2007 ·Journal of Clinical Microbiology ·(unknown), James T. Riordan, (unknown), (unknown), (unknown), (unknown), Frances O’Brien, (unknown), John E. Gustafson	29
15	Contributions of sigB and sarA to distinct multiple antimicrobial resistance mechanisms of Staphylococcus aureus 2006 ·International Journal of Antimicrobial Agents ·James T. Riordan, (unknown), John E. Gustafson	23
16	Response of Staphylococcus aureus to Salicylate Challenge 2006 ·Journal of Bacteriology ·James T. Riordan, Arunachalam Muthaiyan, Wayne Van Voorhies, Christopher T. D. Price, James E. Graham, Brian J. Wilkinson, John E. Gustafson	41
17	Agricultural policy analysis and planning : a summary of two recent analyses of A.I.D.-supported projects worldwide 1988 ·(unknown), James T. Riordan	1
18	Replication of Rubella Virus in a Continuous Line of African Green Monkey Kidney Cells (Vero). 1967 ·Experimental Biology and Medicine ·Harvey Liebhaber, James T. Riordan, Dirk Horstmann	25
19	Thermal Sensitivity of Polioviruses Isolated during Oral Vaccine Field Trial: Comparison with Monkey Neurovirulence 1959 ·Experimental Biology and Medicine ·(unknown), James T. Riordan, Dirk Horstmann	12
20	Differences in Cellular Pathogenicity of Two Immunologically Related Poliomyelitis Viruses as Revealed in Tissue Culture. 1951 ·Experimental Biology and Medicine ·Nada Ledinko, James T. Riordan, J. L. Melnick	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact